What is a Boxed Warning, and what triggers one
What a Boxed Warning actually signals, and the kinds of risk that lead the FDA to require one.
A Boxed Warning is the most serious safety warning that can appear on a prescription drug's label. It's named for its format, a warning literally set off in a bordered box at the top of the prescribing information, and that formatting choice is deliberate: it's meant to be impossible to miss.
What it is
A Boxed Warning highlights a serious or life-threatening risk associated with a drug, one significant enough that the FDA has determined it needs to be called out separately from the rest of the label's safety information rather than folded into a general warnings section. Not every serious side effect gets a Boxed Warning. The designation is reserved for risks the FDA considers severe enough, or common enough given the severity, that prescribers and patients need it presented with maximum visibility before the drug is used.
Why it matters
For promotional content, a Boxed Warning changes what fair balance actually requires. Content promoting a drug that carries a Boxed Warning generally needs to reflect that warning with a level of prominence matching its severity, not treat it as one line item among several safety disclosures. This is a stricter version of the general fair balance requirement, because the underlying risk itself has already been judged more serious by the regulator.
Getting this wrong is a common and serious source of regulatory risk specifically because a Boxed Warning is meant to be the most visible safety information on the label. Promotional content that under-represents it relative to benefit claims isn't just a minor fair balance issue, it's a mismatch with how seriously the regulator has already classified the risk.
How it actually works
A Boxed Warning is typically added or required when:
- A risk is serious or life-threatening, such as a risk of death, permanent injury, or a condition that can become life-threatening if not managed.
- The risk can be mitigated with appropriate use, meaning the warning exists partly to guide safer prescribing and monitoring, not only to disclose the risk exists.
- Post-market data reveals a risk not fully understood at approval, which is why a Boxed Warning can be added to a drug's label well after it's already on the market, as real-world use surfaces risks that clinical trials didn't fully capture.
Because a Boxed Warning can be added after approval, it's not a fixed, one-time classification. A drug's label, and the promotional obligations tied to it, can change over the product's life, which is part of why regulatory review treats current labeling as the source of truth rather than whatever was true at launch.